Today, injectable drugs are the fastest growing drug segment, and the shifts we are seeing in more hospital to home treatment options will change our industry. The growth of GLP-1 drugs have also contributed to the increased demand for these drug delivery systems. To manufacture, formulate and assemble these drug delivery devices, it is important to partner with a CDMO with expertise to assist with process development and to reduce development risk.
In this webinar you will:
-
Learn from West’s expertise in implementing medium and high-volume drug packaging programs
-
Discover best practices for strategic decision makers in technical operations, device teams, external manufacturing, and MSAT
-
Gain insights tailored for emerging and established pharma and biotech companies launching and scaling combination devices
-
And more..